CLDX
#1701
Celldex Therapeutics, Inc. - Common Stock
38.5 3 USD
-0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.48%
Monthly Change
+21.47%
6 month change
+46.84%
Year Change
+41.45%
Previous Close
39.1 1
Open
38.5 3
Low
38.5 3
High
38.5 3
Volume
109
Financials
- Market Capitalization 3.02 B
- Employee 198
- Founded 1983
- CEO N/A
- Website www.celldex.com
- Headquarter Delaware, United States
- FIGI BBG000FW8LZ9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-6.96
Price to sales ratio
1 167.65
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1663 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 36.15 USD | -2.27% | -7.85% | +22.83% | +10.96% | 3.18 B USD | ||
| 1679 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 50.87 USD | -0.43% | +1.27% | +11.48% | +146.22% | 3.10 B USD | ||
| 1713 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 41.50 USD | -1.19% | +3.03% | +19.70% | +39.54% | 2.98 B USD | ||
| 1736 |  IRON Disc Medicine, Inc. - Common Stock | 75.98 USD | -0.80% | -2.71% | +10.02% | +31.02% | 2.90 B USD |
Frequently asked questions about Celldex Therapeutics, Inc. - Common Stock
What is the Celldex Therapeutics, Inc. - Common Stock stock price today?
The current price of Celldex Therapeutics, Inc. - Common Stock (CLDX) is 38.53. Over the past 24 hours, the stock has changed by -1.48%. Follow the CLDX chart for real-time price dynamics.
What is the stock ticker of Celldex Therapeutics, Inc. - Common Stock?
Celldex Therapeutics, Inc. - Common Stock trades under the ticker CLDX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Celldex Therapeutics, Inc. - Common Stock stock going up?
CLDX has changed by +1.39% over the last week, +21.47% over the last month, and +41.45% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Celldex Therapeutics, Inc. - Common Stock net income for the last quarter?
Celldex Therapeutics, Inc. - Common Stock reported net income of -78.69 M for the last quarter. The previous quarter showed -81.32 M, which means net income changed by +3.24%.
How many employees does Celldex Therapeutics, Inc. - Common Stock have?
As of the latest available data, Celldex Therapeutics, Inc. - Common Stock has 198 employees. Workforce size can provide additional context about the company's scale and operations.
What is Celldex Therapeutics, Inc. - Common Stock EBITDA?
Celldex Therapeutics, Inc. - Common Stock EBITDA is -83.58 M, and its EBITDA margin is -557.21 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Celldex Therapeutics, Inc. - Common Stock stock?
You can buy Celldex Therapeutics, Inc. - Common Stock (CLDX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Celldex Therapeutics, Inc. - Common Stock stock?
Investing in Celldex Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CLDX chart and related analysis on metatrader.com as part of your research.